GB2463436A - (11C)methoxy-radiolabelled 2,3',4,5'-tetramethylstilbene (TMS) and its preparation and use - Google Patents

(11C)methoxy-radiolabelled 2,3',4,5'-tetramethylstilbene (TMS) and its preparation and use Download PDF

Info

Publication number
GB2463436A
GB2463436A GB1001001A GB201001001A GB2463436A GB 2463436 A GB2463436 A GB 2463436A GB 1001001 A GB1001001 A GB 1001001A GB 201001001 A GB201001001 A GB 201001001A GB 2463436 A GB2463436 A GB 2463436A
Authority
GB
United Kingdom
Prior art keywords
methoxy
radiolabelled
tms
methods
tetramethoxystilbene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB1001001A
Other versions
GB201001001D0 (en
Inventor
Timothy Smith
Lutz F Schweiger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Aberdeen
Original Assignee
University of Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Aberdeen filed Critical University of Aberdeen
Publication of GB201001001D0 publication Critical patent/GB201001001D0/en
Publication of GB2463436A publication Critical patent/GB2463436A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

This invention pertains generally to the field of radiochemical synthesis, and more specifically to methods of preparing [11C]methoxy-radiolabelled 2,3',4,5' -tetramethoxystilbene (TMS) from an unlabelled hydroxy precursor of 2,3',4,5' -tetramethoxystilbene (TMS) that has a pendant hydroxyl group, by reaction with [11C]methyl trifluoromethanesulfonate (CF3SO2O11CH3), also known as [11C]methyl triflate, or [11C]methyl iodide (11CH3I). This reaction converts the pendant hydroxyl group into a pendant [11C]methoxy group. The resulting [11C]methoxy-radiolabelled product is useful, for example, as an in vivo positron emission tomography (PET) tracer, for example, for tumours (e.g., cancer tumours) and/or beta amyloid plaques (e.g., Alzheimer's disease). The present invention also pertains to the resulting [11C]methoxy radiolabelled products, compositions comprising them, their use in methods of (e.g., PET) imaging, their use in methods of medical treatment and diagnosis, etc.
GB1001001A 2007-06-22 2008-06-20 (11C)methoxy-radiolabelled 2,3',4,5'-tetramethylstilbene (TMS) and its preparation and use Withdrawn GB2463436A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94562507P 2007-06-22 2007-06-22
PCT/GB2008/002111 WO2009001046A2 (en) 2007-06-22 2008-06-20 [11c]methoxy-radiolabelled 2,3',4,5'-tetramethylstilbene (tms) and its preparation and use

Publications (2)

Publication Number Publication Date
GB201001001D0 GB201001001D0 (en) 2010-03-10
GB2463436A true GB2463436A (en) 2010-03-17

Family

ID=39816887

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1001001A Withdrawn GB2463436A (en) 2007-06-22 2008-06-20 (11C)methoxy-radiolabelled 2,3',4,5'-tetramethylstilbene (TMS) and its preparation and use

Country Status (2)

Country Link
GB (1) GB2463436A (en)
WO (1) WO2009001046A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI644665B (en) * 2017-12-08 2018-12-21 衛生福利部國家中醫藥研究所 Use of stilbene and benzofuran derivatives for the treatment of neurological diseases

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003018013A1 (en) * 2001-08-31 2003-03-06 Promeditech, Inc. Stilbene derivative having cytochrome p450 1b1 inhibitory activity, pharmaceutically acceptable salt thereof, method for preparing the same, and composition including the same
WO2006066104A2 (en) * 2004-12-17 2006-06-22 The Trustees Of The University Of Pennsylvania Stilbene derivatives and their use for binding and imaging amyloid plaques

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003018013A1 (en) * 2001-08-31 2003-03-06 Promeditech, Inc. Stilbene derivative having cytochrome p450 1b1 inhibitory activity, pharmaceutically acceptable salt thereof, method for preparing the same, and composition including the same
WO2006066104A2 (en) * 2004-12-17 2006-06-22 The Trustees Of The University Of Pennsylvania Stilbene derivatives and their use for binding and imaging amyloid plaques

Also Published As

Publication number Publication date
WO2009001046A2 (en) 2008-12-31
WO2009001046A3 (en) 2009-02-26
GB201001001D0 (en) 2010-03-10

Similar Documents

Publication Publication Date Title
BRPI0515175A (en) method for radiofluorination, compound, radiopharmaceutical composition, use of a radiolabelled conjugate or salt thereof, method for in vivo diagnosis or imaging of a disease or condition associated with angiogenesis, and method for monitoring the effect of treatment of a human or animal body with a medicine to combat a condition associated with cancer
Ono et al. 99mTc/Re complexes based on flavone and aurone as SPECT probes for imaging cerebral β-amyloid plaques
MX348958B (en) Methods and apparatus for synthesizing imaging agents, and intermediates thereof.
NZ590923A (en) Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
CN112770785A (en) Labeled inhibitors of Prostate Specific Membrane Antigen (PSMA), their use as imaging agents and agents for treating PSMA-expressing cancers
WO2009052970A3 (en) Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors
GB0322756D0 (en) Methods of chemical synthesis
WO2011044410A3 (en) Solid phase extraction purification method
WO2016118188A1 (en) Compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells
WO2010039609A3 (en) Conjugates of hexose and metal coordinating compounds for imaging purposes
AU2017203512B2 (en) 18F-saccharide-folates
US10537650B2 (en) Molecular probes for multimodality imaging and tracking of stem cells
EP2291075A4 (en) Gastrin releasing peptide compounds
Paparidis et al. Synthesis and evaluation of 99mTc/Re-tricarbonyl complexes of the triphenylphosphonium cation for mitochondrial targeting
KR101523249B1 (en) Method for labelling exosome with radioisotope and its use
Dapueto et al. Biological evaluation of glucose and deoxyglucose derivatives radiolabeled with [99mTc (CO) 3 (H2O) 3]+ core as potential melanoma imaging agents
BRPI0917147B8 (en) compound or salt thereof, use of a compound or salt thereof, and process for making a compound
McLarty et al. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice
Yang et al. Preclinical evaluation of an 18 F-trifluoroborate methionine derivative for glioma imaging
GB2463436A (en) (11C)methoxy-radiolabelled 2,3',4,5'-tetramethylstilbene (TMS) and its preparation and use
Fellner et al. Assessing p-Glycoprotein (Pgp) Activity In Vivo Utilizing 68 Ga–Schiff Base Complexes
WO2010096426A8 (en) Compounds, compositions, methods of synthesis, and methods of treatment
NZ591824A (en) Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system
MX340487B (en) Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system.
EP2900278B1 (en) Radiopharmaceutical products for diagnosis and therapy of adrenal carcinoma

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)